Astrazeneca Pharma India informs about loss of share certificates

19 Nov 2022 Evaluate
Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Astrazeneca Pharma India has informed that the Registrar and Transfer Agents of the Company, Integrated Registry Management Services have informed the Company on the attached request for Loss of Share Certificate from the claimant.

The above information is a part of company’s filings submitted to BSE.

Astrazeneca Pharma I Share Price

8842.60 -8.00 (-0.09%)
27-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1738.10
Dr. Reddys Lab 1287.20
Cipla 1347.65
Zydus Lifesciences 922.50
Lupin 2301.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×